Nigeria NAFDAC Greenbook Medical Device Registry: Licenses & Expiry Cycles

A comprehensive, data-driven analysis of the Nigeria NAFDAC Greenbook medical device registry. Explore active vs. inactive license ratios, top applicants, and the 5-year renewal cycle.

Executive Summary

What does the NAFDAC Greenbook database reveal about active vs. inactive medical device licenses, top applicants, and product categories in Nigeria?

The NAFDAC Greenbook database contains 1,119 registered medical device and IVD records, with a high active rate of 93.57% (1,047 active licenses) vs. 6.43% (72 inactive licenses). Roche Products Limited is the top applicant with 43 registrations, focusing on diagnostic and point-of-care test kits (like CoaguChek and Accutrend). Hayat Kimya Nigeria Ltd follows with 37 registrations. The dataset is dominated by daily-use or disposable devices, with Nappy (Diaper) Pants representing 102 registrations, Sanitary Pads representing 94, and Gloves representing 80. Registrations follow a strict 5-year validity cycle, with approvals peaking in 2023 (346 approvals) and 2024 (261 approvals).

Introduction to the Nigerian Medical Device Market

Nigeria represents the largest consumer market in Africa, with a population exceeding 220 million and a growing demand for modern healthcare solutions. The country’s medical device and diagnostic sector relies heavily on foreign imports, presenting a significant opportunity for international medtech manufacturers.

The commercialization, importation, and distribution of medical devices in Nigeria are regulated by the National Agency for Food and Drug Administration and Control (NAFDAC). Established under Act No. 15 of 1993, NAFDAC is responsible for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale, and use of food, drugs, cosmetics, medical devices, bottled water, and chemicals.

To provide clear market intelligence, MedDeviceGuide has performed a comprehensive, database-level analysis of the medical device listings in the official NAFDAC Greenbook database (greenbook.nafdac.gov.ng) based on the latest registry extract dated June 22, 2026. This analysis maps out the active vs. inactive status of product licenses, identifies the most active local applicant companies, analyzes the product categories dominating the registry, and proves the chronological distribution of approvals and expiries under NAFDAC’s 5-year renewal cycle.

Understanding these parameters allows manufacturers to answer key operational questions: Which local applicants hold the most active NAFDAC registrations? How many licenses are active versus inactive, and what does the 5-year renewal cycle reveal about upcoming expiry waves? Which product categories and diagnostics brands dominate the Greenbook? Below, we explore these database metrics to provide actionable intelligence for medtech market access.

NAFDAC's Regulatory Framework and Classification

NAFDAC regulates medical devices and in vitro diagnostics (IVDs) using a risk-based classification system, matching global Harmonization Task Force (GHTF) guidelines:

Class A (Low Risk): Tongue depressors, non-sterile examination gloves, bandages, and basic surgical drapes.
Class B (Low-to-Moderate Risk): Hypodermic needles, urinary catheters, and basic diagnostic test reagents.
Class C (Moderate-to-High Risk): Infusion pumps, lung ventilators, and diagnostic test kits for infectious diseases.
Class D (High Risk): Implantable pacemakers, coronary stents, orthopedic joint implants, and blood-bag systems.

To import or manufacture medical devices in Nigeria, the product must be registered via the NAFDAC Automated Product Administration and Monitoring System (NAPAMS) portal. Foreign manufacturers must appoint a local representative—a registered Nigerian company—who submits the dossier on their behalf and is designated as the "Applicant" in the Greenbook database.

Active vs. Inactive License Ratios in the Greenbook

A key metric in the NAFDAC Greenbook registry is the active status of a license. In many emerging markets, registries are cluttered with expired, historical product entries that have not been imported for years. NAFDAC, however, actively maintains its Greenbook portal to reflect current, authorized items.

Our database analysis of the 1,119 registered medical device and IVD records shows the following:

Active Licenses: 1,047 records (93.57%)
Inactive Licenses: 72 records (6.43%)
Total Database Listings: 1,119 records (100.00%)

This exceptionally high active rate (93.57%) indicates that NAFDAC actively purges or marks listings as "Inactive" when they fail to undergo renewal. For foreign manufacturers, this underscores the importance of maintaining compliance; if a registration expires, the Greenbook listing is set to inactive, prompting immediate custom clearance blocks at Nigerian ports of entry.

The Leading Medical Device Applicants in Nigeria

To distribute products in Nigeria, foreign manufacturers must partner with a local applicant. Similar to other West African markets, a handful of local distributors, diagnostic specialists, and consumer hygiene manufacturers hold the majority of registered listings.

The top 10 local applicants hold a combined 254 registrations, representing 22.70% of the entire database:

Rank	Local Applicant Name	Active Listings	Percentage of Database	Primary Focus Area
1	Roche Products Limited	43	3.84%	Clinical Diagnostics, Point-of-Care Kits (e.g., CoaguChek, Accutrend)
2	Hayat Kimya Nigeria Ltd	37	3.31%	Consumer Hygiene, Baby Care (e.g., Molfix diaper pants)
3	CHI Pharmaceutical Limited	30	2.68%	Diagnostics, general medical consumables, pharmaceutical lines
4	Uni-Medical Healthcare Limited	29	2.59%	Clinical consumables, syringes, infusion sets
5	Deep K. Tyagi Foundation Nigeria	26	2.32%	Diagnostic screening kits, rapid test systems
6	Nel Apex Global Ltd	21	1.88%	General hospital supplies, clinical disposables
7	Kcssa West Africa Limited	20	1.79%	Advanced diagnostic systems, laboratory reagents
8	Nighana Offices Limited	18	1.61%	Consumer hygiene, absorbent surgical pads
9	Daraju Industries Limited	15	1.34%	Personal care devices, dental consumables (e.g., toothbrushes)
10	Century Industrial FZE	15	1.34%	Industrial surgical consumables, gloves, syringes

NAFDAC Top Applicant Registry Share (Top 5):
Roche Products:    [=======================] 43
Hayat Kimya:       [====================] 37
CHI Pharm:         [================] 30
Uni-Medical:       [===============] 29
Deep K. Tyagi:     [==============] 26

Roche Products Limited: Leading the Diagnostics Space

Roche Diagnostics dominates the medical device registry in Nigeria with 43 active registrations (3.84%). These listings are highly concentrated in in vitro diagnostics (IVDs) and point-of-care testing (POCT) systems. Roche's portfolio includes well-known brands like CoaguChek (prothrombin time monitoring) and Accutrend (glucose/cholesterol testing). This focus reflects the high demand in Nigerian private and public clinics for reliable, decentralized diagnostic systems.

Consumer Hygiene and Disposables

The prominence of Hayat Kimya Nigeria Ltd (37 registrations) and Daraju Industries Limited (15 registrations) highlights a unique classification quirk of NAFDAC: consumer hygiene items (such as baby diaper pants, sanitary pads, and toothbrushes) are regulated under the medical device category. While these items are commercialized outside clinical settings, their regulatory pathway requires compliance with NAFDAC medical device manufacturing and packaging guidelines.

Product Category Distribution: Consumables and Diagnostics

Analyzing the ingredient_name field—which NAFDAC uses to classify the primary material or category of the device—reveals the types of medical technology most frequently registered in Nigeria:

Rank	NAFDAC Product Ingredient/Category	Active Listings	Database Percentage	Typical Device Class
1	Nappy (Diaper) Pants	102	9.11%	Class A (Hygiene)
2	Medical Device (Generic)	96	8.58%	Classes B, C, D (Surgical/Hardware)
3	Sanitary Pads	94	8.40%	Class A (Hygiene)
4	Gloves	80	7.15%	Class A/B (Consumables)
5	Test Kit	46	4.11%	Class B/C (Diagnostics)
6	Infusion Set	39	3.49%	Class B (Consumables)
7	Toothbrush	38	3.40%	Class A (Personal Care)
8	Gauze and Bandages	35	3.13%	Class A (Consumables)
9	Condoms	35	3.13%	Class B (Barrier)
10	Cannula	25	2.23%	Class B (Consumables)
11	Hand Sanitizer	24	2.15%	Class A/B (Sanitization)
12	Blood Bags	21	1.88%	Class C (Blood Collection)
13	Blood Transfusion Set	20	1.79%	Class B (Consumables)
14	Syringes and Needles	20	1.79%	Class B (Consumables)
15	Needles	20	1.79%	Class B (Consumables)

This distribution indicates that the NAFDAC Greenbook is heavily weighted toward high-volume clinical consumables, rapid test kits, and consumer hygiene items. High-value capital equipment (like CT scanners or linear accelerators) is registered under the generic "Medical device" term but represents a lower volume of overall active registry records.

Decoupling NAFDAC's Strict 5-Year Expiry and Approval Cycle

One of the most valuable findings from our database analysis is the strict alignment of NAFDAC’s registration timeline. By comparing the year of approval (approval_date) against the year of expiration (expiry_date) for all active records, we can confirm that NAFDAC registrations are valid for exactly 5 years.

The table below maps the approvals and expiries year-by-year:

Year of Approval	Number of Approvals	Year of Expiration	Number of Expiries
2020	24	2025	24
2021	172	2026	179
2022	219	2027	215
2023	346	2028	344
2024	261	2029	262
2025	95	2030	95

NAFDAC Registration Validity Mapping:
Approved 2021: [===================] 172
Expiring 2026: [====================] 179

Approved 2022: [========================] 219
Expiring 2027: [=======================] 215

Approved 2023: [======================================] 346
Expiring 2028: [======================================] 344

This close mathematical alignment (e.g., 346 approvals in 2023 matching 344 expiries in 2028) demonstrates that NAFDAC rarely deviates from its 5-year validity rule. The slight discrepancies (such as 172 approvals in 2021 vs. 179 expiries in 2026) are due to post-approval amendments, secondary packaging extensions, or administrative corrections that adjust the expiration date by a few months.

What Happens When a License Becomes Inactive?

If a manufacturer fails to submit their renewal application before the 5-year expiry date:

Status Change: NAFDAC updates the Greenbook status from "Active" to "Inactive."
Custom Block: Customs officials at Lagos Port (Apapa/Tincan) and Abuja Airport immediately freeze shipments containing the product.
Late Penalties: NAFDAC charges a substantial "Late Renewal Fee" for submissions received after the expiry date.
Re-Registration Risk: If the registration remains inactive for more than 12 months, NAFDAC may require the manufacturer to submit a completely new registration dossier, necessitating repeat laboratory analysis and GMP inspections.

The 2028 Expiry Warning

The registry data reveals a major peak in approvals in 2023 (346 records). Consequently, 2028 represents a massive expiry wave (344 records). For manufacturers who secured approvals during NAFDAC's digital push in 2023, initiating the renewal process through their local applicants should begin early in 2028 to prevent custom delays.

Renewal Timing Decision Rule

Because NAFDAC enforces a rigid 5-year window, manufacturers should anchor renewal planning to the original approval year rather than waiting for an expiry notice. The data shows that approvals cluster heavily in 2023 and 2024, which means 2028 and 2029 will see the largest expiry waves and the heaviest renewal competition for NAFDAC evaluator capacity.

Original Approval Year	Expiry Year	Recommended Renewal Start	Risk If Delayed
2021	2026	Already overdue if unsubmitted	Inactive listing, customs seizure at Apapa/Tincan
2022	2027	Begin mid-2026	Renewal queue congestion
2023	2028	Begin mid-2027	Peak 2028 expiry wave; multi-month backlog
2024	2029	Begin mid-2028	Second-largest expiry cohort
2025	2030	Begin late 2028	Manageable, but early submission avoids later pile-up

A practical rule is to initiate the renewal dossier at least 12 months before expiry, because NAFDAC requires refreshed laboratory testing, an updated GMP status, and a current local applicant authorization before re-issuing the registration number. Manufacturers whose 2023 approvals are nearing their 2028 cliff should treat mid-2027 as the hard internal deadline.

Common Renewal Failure Modes

Beyond simple missed deadlines, three recurring failure patterns appear in markets operating a strict 5-year cycle like NAFDAC's. First, applicant turnover: when the original local applicant dissolves, merges, or loses its NAFDAC good-standing status, the registration cannot be renewed in place and must be transferred first, often requiring a fresh authorization letter and a notarized power of attorney. Second, specification drift: if the manufacturer has changed a raw-material supplier, secondary packaging site, or sterilization method since the original approval, NAFDAC treats the renewal as a variation and may demand supplementary laboratory testing, extending the cycle by several months. Third, labeling non-conformity: updated NAFDAC formatting requirements introduced since the original approval can trigger a labeling re-review during renewal. Mapping each active registration against these three risks well before its expiry year is the single most effective way to avoid an involuntary inactive status and the customs seizures that follow.

NAFDAC GMP Facility Audit and Desk Review Guidelines

NAFDAC places high priority on verifying the manufacturing environment of imported medical devices. To achieve this, the agency mandates a Good Manufacturing Practice (GMP) audit of the production site before issuing a marketing authorization certificate.

Physical Plant Inspections

Under standard procedures, NAFDAC sends a delegation of two inspectors to physically audit the foreign manufacturer's facility. The manufacturer must cover all travel, accommodation, and daily allowance costs for the inspectors, in addition to the official NAFDAC audit fee. This requirement can add $10,000 to $20,000 to the cost of registration and extend the timeline by 6 to 12 months due to inspector scheduling backlogs.

The Desk Review Pathway (Audit Waiver)

To reduce backlogs and lower costs for manufacturers, NAFDAC has established a Desk Review pathway. Manufacturers can apply for a waiver of the physical inspection if they submit a comprehensive GMP Desk Review dossier proving their facility has been audited by a recognized regulatory body.

To qualify for a NAFDAC Desk Review, the manufacturer must submit:

MDSAP Audit Report: A recent (within 3 years) audit report under the Medical Device Single Audit Program.
MDSAP Certificate: A valid certificate covering the manufacturing site.
ISO 13485 Certificate: Issued by an accredited registrar.
Reference Approvals: Proof of active marketing authorization from a reference regulator (such as US FDA, EU Notified Body, or Health Canada).
Recent Regulatory Inspection Reports: The most recent inspection report from the home regulator (e.g., FDA Establishment Inspection Report - EIR).

If the Desk Review is approved, NAFDAC issues a GMP compliance letter, allowing the registration process to proceed without a physical site audit, saving significant time and cost.

Step-by-Step Pathway to NAFDAC Registration

Securing marketing authorization in Nigeria is a multi-stage process that requires coordination between the foreign manufacturer and the local applicant. For a broader look at procurement, consult our companion Nigeria medical device procurement guide. The registration path includes:

graph TD
    A[Appoint Nigeria Local Applicant & Execute Power of Attorney] --> B[Prepare Dossier & Legalize Certificate of Free Sale]
    B --> C[Apply for NAFDAC Import Permit for Samples]
    C --> D[Import Product Samples and Pay Evaluation Fees]
    D --> E[Submit Samples to NAFDAC Central Laboratory Yaba]
    E --> F[NAFDAC Technical Dossier Evaluation]
    F --> G{Did Lab Analysis & Dossier Review Pass?}
    G -->|No| H[Respond to Compliance Query within 30 Days]
    G -->|Yes| I[Conduct NAFDAC GMP Facility Audit or Desk Review]
    H --> F
    I --> J[Approval Meeting of NAFDAC Registration Committee]
    J --> K[Issue NAFDAC Registration Number & Certificate: 5 Years]
    K --> L[Maintain Active Listing in NAFDAC Greenbook]

Select and Appoint the Local Applicant: Issue a Power of Attorney (PoA) authorizing the local representative to register the product. The PoA must be notarized in the country of origin and authenticated by the Nigerian Embassy.
Dossier Compilation: Compile the technical dossier. Key requirements include:
- Certificate of Free Sale (CFS) from the country of origin.
- CE Certificate or US FDA clearance.
- ISO 13485 certification.
- Comprehensive formulation, raw materials specification, and secondary packaging drawings.
- Bilingual labeling (English must be prominent) including NAFDAC formatting requirements.
Import Permit for Samples: Apply for a specialized import permit to bring product samples and clinical testing reagents into Nigeria.
Laboratory Analysis: Once samples arrive, they must be submitted to the NAFDAC Central Laboratory (typically the Yaba Laboratory in Lagos or the Kaduna Laboratory) for physical, chemical, and sterility testing.
GMP Facility Audit: For Class B, C, and D devices, NAFDAC conducts a physical inspection of the foreign manufacturing facility to verify compliance with Good Manufacturing Practices (GMP). Under certain conditions, NAFDAC may accept a "Desk Review" of the manufacturing facility if the firm possesses a recent audit report from a recognized regulator (e.g., MDSAP or EU Notified Body).
NAFDAC Approval Committee Meeting: Upon passing the laboratory testing, technical review, and GMP audit, the dossier is presented to the NAFDAC Registration Committee for final marketing authorization.
Greenbook Listing: Upon approval, a unique NAFDAC Registration Number is issued (e.g., 03-1467 for Abbott’s malaria kits), and the product is listed as "Active" in the Greenbook database.

Regional Comparison: Nigeria vs. Ghana vs. Kenya

West and East African markets exhibit distinct differences in regulatory timelines, fees, and post-market controls. The table below compares Nigeria NAFDAC with its West African neighbor Ghana FDA and East African peer Kenya PPB:

Parameter	Nigeria (NAFDAC)	Ghana (FDA)	Kenya (PPB)
National Regulator	National Agency for Food and Drug Admin	Food and Drugs Authority, Ghana	Pharmacy and Poisons Board, Kenya
Registration Validity	5 Years	3 Years (Imported), 5 Years (Local)	5 Years
Laboratory Testing?	Mandatory (for almost all classes)	Selective (based on risk)	Selective (based on risk)
GMP Audits	Mandatory (Desk Review possible)	Mandatory (Desk Review possible)	Mandatory (Desk Review possible)
Average Timeline	6 to 12 Months	4 to 8 Months	3 to 6 Months
Registry Database	Greenbook Portal (Public)	Registered Products List (PDF/Online)	PRIMS Portal (Licensed LTRs only)

Strategic Takeaways for Medtech Exporters

Monitor the 2028 Renewal Backlog: If your registrations were secured in 2023, prepare for a slow renewal cycle in 2028. Work with your local applicant to submit the renewal application at least 6 months before the expiration date.
Ensure Strict Lab Compliance: Since NAFDAC requires mandatory laboratory testing of sample shipments at Yaba or Kaduna, verify that the clinical testing parameters, sample volumes, and control reagents shipped match NAFDAC specifications exactly. A sample rejection can delay registration by 3 to 6 months.
Structure LTR/Applicant Agreements Carefully: Tying a registration to a local applicant who owns the NAFDAC number can lead to distribution lock-in. Draft agreements that allow for the transfer of the NAFDAC registration to a different distributor if commercial terms are not met.
Confirm Greenbook Listing Active Status: Routinely audit your NAFDAC Greenbook listings. If a listing switches to "Inactive," work immediately with your representative to identify if a late annual fee or QMS update is the cause, preventing custom seizures.

Frequently Asked Questions (FAQs)

How long is a NAFDAC medical device registration valid in Nigeria?

NAFDAC registrations are valid for exactly five years. This is mathematically confirmed by the database alignment of approval and expiry years.

Which applicant holds the most medical device registrations in the NAFDAC Greenbook?

Roche Products Limited holds the most registrations with 43 active listings, focusing primarily on diagnostic kits and point-of-care instruments.

Can a foreign manufacturer register a medical device directly with NAFDAC?

No. Foreign manufacturers cannot register directly. They must appoint a registered Nigerian company as their Local Representative/Applicant, who acts as the primary contact for NAFDAC and holds the marketing authorization certificate.

What are the language requirements for medical device labeling in Nigeria?

All product labels, packaging inserts, instructions for use (IFU), and manuals must be printed in English. English text must be clear, prominent, and include the NAFDAC registration number once approved.

How much does a NAFDAC registration cost?

The NAFDAC fee depends on whether the device is imported or locally manufactured. For imported devices, the total registration fee (including registration, GMP audit/desk review, and laboratory testing) typically ranges from $2,500 to $5,000, excluding shipping and customs clearance for sample materials.

Sources and Database Metadata

Primary Dataset: NAFDAC Greenbook Product Database: https://greenbook.nafdac.gov.ng
Official Regulator Website: NAFDAC Guidelines and Publications: https://nafdac.gov.ng
National Health Authority: National Health Insurance Authority (NHIA) Portal: https://nhia.gov.ng
Analysis Extract Date: June 22, 2026.
Total Analyzed Sample: 1,119 medical device and IVD records (1,047 active, 72 inactive).

Disclaimer: The statistical data and insights presented in this analysis are derived from the NAFDAC Greenbook public database extract dated June 22, 2026. They are intended for educational and strategic planning purposes only. Manufacturers must verify current registration fees, dossier requirements, and GMP audit protocols directly with NAFDAC or their appointed local representatives before making commercial decisions.